Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

19. Juni 2025 08:20 ET | Quelle: Theranica

Theranica to Present Three Real-World Evidence Studies at AHS Scientific Meeting Highlighting the Impact of the Nerivio® REN Wearable on Migraine Treatment

Theranica is presenting three real-world evidence studies at the American Headache Society (AHS) 67th Annual Scientific Congress.
22. April 2025 08:10 ET | Quelle: Theranica

Theranica Announces Coverage Policy from the Second Largest U.S. Health Insurer for Its Nerivio® REN Wearable Migraine Treatment, Reaching Access for 80 Million Americans

BRIDGEWATER, N.J. and NETANYA, Israel, April 22, 2025 (GLOBE NEWSWIRE) -- Theranica, a prescribed neuromodulation therapeutics company, today announced that that its FDA-cleared, non-drug,...
05. Februar 2025 17:10 ET | Quelle: Theranica

The Largest Insurance Provider in Massachusetts Publishes Positive Reimbursement Policy for the Nerivio® REN Wearable for Acute and Preventive Treatment of Migraine

BRIDGEWATER, N.J. and NETANYA, Israel, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Theranica, a prescribed neuromodulation therapeutics company, today announced a coverage decision from the largest health...